Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT05784740

Precision Exercise to Improve Outcomes in Sepsis

Led by University of British Columbia · Updated on 2024-12-18

32

Participants Needed

1

Research Sites

119 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

V

Vancouver Coastal Health Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this interventional clinical research study is to assess the efficacy of a 12-week precision exercise training intervention to improve exercise tolerance in sepsis survivors. The main question it aims to answer is does a 12-week precision exercise training program improve constant load exercise time in sepsis survivors? Participants will: * Answer questionnaires related to patient reported outcomes and give a blood sample * Perform a constant load exercise test * Complete 12-weeks (3 x per week, 36 session in total) of precision exercise training consisting of individualized, nonlinear periodized strength and aerobic exercise training. Researchers will compare the exercise group to an attention control group of sepsis survivors who do not receive exercise training but instead undergo usual care procedures and receive general lifestyle advice 1x per week.

CONDITIONS

Official Title

Precision Exercise to Improve Outcomes in Sepsis

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent
  • At least 19 years of age
  • At least 60 days prior to enrollment, known or suspected infection with at least two quickSOFA criteria: respiratory rate >22 breaths/min, altered mentation, or systolic blood pressure <100 mmHg
  • Cardiorespiratory fitness below 80% of age and sex-predicted norms
  • Ability to attend 3 exercise sessions per week for 12 weeks
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Currently on supplemental oxygen
  • Known previous cardiac or cerebral vascular events in the past 90 days
  • Diabetes
  • Autoimmune diseases or on daily immunomodulatory drugs
  • Obstructive sleep apnea
  • Uncontrolled hypertension
  • Known pregnancy, intending to become pregnant within 28 days of enrollment, or breastfeeding
  • Oxygen saturation below 85% during exercise
  • Cardiovascular contraindications or musculoskeletal limitations to exercise as assessed during testing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

St. Paul's Hospital - Centre for Heart Lung Innovation

Vancouver, British Columbia, Canada

Actively Recruiting

Loading map...

Research Team

G

Graeme Koelwyn, PhD

CONTACT

J

John Boyd, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here